CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −2,498 | 2,497 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +1,592 | 28,601 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +1,750 | 30,351 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +2,694 | 33,045 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −2,920 | $33.49 | $98K | 30,125 |
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Restricted Share Unit | +12,275 | 12,275 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Share Option | +39,363 | 39,363 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,592 | 4,773 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,750 | 3,500 | ||
| 2025-09-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −2,694 | 2,694 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +6,238 | 102,912 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +6,481 | 109,393 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +9,992 | 119,385 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −10,983 | $33.49 | $368K | 108,402 |
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Restricted Share Unit | +34,435 | 34,435 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Share Option | +137,638 | 137,638 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,238 | 18,712 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,481 | 12,962 | ||
| 2025-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −9,992 | 9,991 | ||
| 2025-08-18 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +6,500 | $8.83 | $57K | 56,415 |
Page 26 of 74 · 1,467 trades